Back to search
FDAFDA · Food and drugs·Recall number D-0068-2022

Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15

Published November 3, 2021 · Recall initiated: October 12, 2021

Summary

FDA records drug Class III recall D-0068-2022, published November 3, 2021 and initiated October 12, 2021. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 22,752 blister packs; Lot: Lot #: AC14635, Exp. Date 12/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Moisture Limits

What to do

Voluntary: Firm initiated · Letter

Get an email if LORATADINE AND PSEUDOEPHEDRINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LORATADINE AND PSEUDOEPHEDRINE SULFATE
Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Nationwide within the United States
Lot
Lot #: AC14635, Exp. Date 12/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15 recalled?

Yes. FDA published recall D-0068-2022 on November 3, 2021. Reported hazard: Failed Moisture Limits

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LORATADINE AND PSEUDOEPHEDRINE SULFATE.